Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibition of human matriptase by eglin c variants

20 Mar 2006

Abstract excerpt

Based on the enzyme specificity of matriptase, a type II transmembrane serine protease (TTSP) overexpressed in epithelial tumors, we screened a cDNA library expressing variants of the protease inhibitor eglin c in order to identify potent matriptase inhibitors. The most potent of these, R(1)K(4)'-eglin, which had the wild-type Pro(45) (P1 position) and Tyr(49) (P4' position) residues replaced with Arg and Lys,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation and Thrombosis Mechanisms
Share to Coagulation, Bradykinin, Polyphosphates, and Angioedema
Share to Protein Kinase Regulation and GTPase Signaling

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16566926
DOI: 10.1016/j.febslet.2006.03.030

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibition of human matriptase by eglin c variantsPMID 16566926Read ↗

Insights into matriptase-2 substrate binding and inhibition mechanisms by analyzing active-site-mutated variants.Semantic proximity Read ↗

Proteolytic cleavage of Trop2 at Arg87 is mediated by matriptase and regulated by Val194.Semantic proximity Read ↗

Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface.Semantic proximity Read ↗

The type II transmembrane serine protease matriptase-2--identification, structural features, enzymology, expression pattern and potential roles.Semantic proximity Read ↗

Type II transmembrane serine proteases as potential targets for cancer therapySemantic proximity Read ↗

Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway.Semantic proximity Read ↗

Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndromeSemantic proximity Read ↗

Mutation G827R in matriptase causing autosomal recessive ichthyosis with hypotrichosis yields an inactive protease.Semantic proximity Read ↗

The activity of a designer tissue inhibitor of metalloproteinases (TIMP)-1 against native membrane type 1 matrix metalloproteinase (MT1-MMP) in a cell-based environment.Semantic proximity Read ↗

Autosomal Ichthyosis with Hypotrichosis Syndrome Displays Low Matriptase Proteolytic Activity and Is Phenocopied in ST14 Hypomorphic MiceSemantic proximity Read ↗

Mild acidity likely accelerates the physiological matriptase autoactivation process: a comparative study between spontaneous and acid-induced matriptase zymogen activation.Semantic proximity Read ↗

The activity of a type II transmembrane serine protease, matriptase, is dependent solely on the catalytic domain.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.